Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

Por Leonard, Gregory D, Wright, Maurice A, Quinn, Mary G, Fioravanti, Suzanne, Harold, Nancy, Schuler, Barbara, Thomas, Rebecca R, Grem, Jean L
Publicado em 2005

Molecular and Clinical Responses in a Pilot Study of Gefitinib with Paclitaxel and Radiation in Locally Advanced Head and Neck Cancer

Por Van Waes, Carter, Allen, Clint T., Citrin, Deborah, Gius, David, Colevas, A. Dimetrios, Harold, Nancy A., Rudy, Susan, Nottingham, Liesl, Muir, Christine, Chen, Zhong, Singh, Anurag K., Dancey, Janet, Morris, John C.
Publicado em 2009

A phase I study of TRC105 anti-endoglin ( CD 105) antibody in metastatic castration-resistant prostate cancer

Por Karzai, Fatima H., Apolo, Andrea B., Cao, Liang, Madan, Ravi A., Adelberg, David E., Parnes, Howard, McLeod, David G., Harold, Nancy, Peer, Cody, Yu, Yunkai, Tomita, Yusuke, Lee, Min-Jung, Lee, Sunmin, Trepel, Jane B., Gulley, James L., Figg, William D., Dahut, William L.
Publicado no BJU Int (2015)

Phase II trial of docetaxel, bevacizumab, lenalidomide and prednisone in patients with metastatic castration-resistant prostate cancer

Por Madan, Ravi A., Karzai, Fatima H., Ning, Yang-Min, Adesunloye, Bamidele A., Huang, Xuan, Harold, Nancy, Couvillon, Anna, Chun, Guinevere, Cordes, Lisa, Sissung, Tristan, Beedie, Shaunna L., Dawson, Nancy A., Theoret, Marc R., McLeod, David G., Rosner, Inger, Trepel, Jane B., Lee, Min-Jung, Tomita, Yusuke, Lee, Sunmin, Chen, Clara, Steinberg, Seth M., Arlen, Philip M., Gulley, James L., Figg, William D., Dahut, William L.
Publicado no BJU Int (2016)